FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Marc Carrier

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
R A Rodriguez; Marc Carrier; Philip S Wells
Non-adherence to new oral anticoagulants: a reason for concern during long-term anticoagulation?
Marc Carrier; A A Khorana; Grégoire LE GAL; A Y Y Lee; G H Lyman; J I Zwicker
Venous thromboembolism in cancer clinical trials: recommendation for standardized reporting and analysis.
Grégoire LE GAL; Marc Carrier; Marc Rodger
Clinical decision rules in venous thromboembolism.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Marc Carrier (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: R A Rodriguez; Marc Carrier; Philip S Wells
Non-adherence to new oral anticoagulants: a reason for concern during long-term anticoagulation?
Journal of thrombosis and haemostasis : JTH 2013;11(2):390-4.
2012: Marc Carrier; A A Khorana; Grégoire LE GAL; A Y Y Lee; G H Lyman; J I Zwicker
Venous thromboembolism in cancer clinical trials: recommendation for standardized reporting and analysis.
Journal of thrombosis and haemostasis : JTH 2012;10(12):2599-601.
2012: Grégoire LE GAL; Marc Carrier; Marc Rodger
Clinical decision rules in venous thromboembolism.
Best practice & research. Clinical haematology 2012;25(3):303-17.
2012: Andrew Aw; Marc Carrier; Joshua Koczerginski; Sheryl McDiarmid; Jason Tay
Incidence and predictive factors of symptomatic thrombosis related to peripherally inserted central catheters in chemotherapy patients.
Thrombosis research 2012;130(3):323-6.
2012: Marc Carrier; Marc Righini; Grégoire LE GAL
Symptomatic subsegmental pulmonary embolism: what is the next step?
Journal of thrombosis and haemostasis : JTH 2012;10(8):1486-90.
2012: Martha L Louzada; Guy Meyer; Timothy O Ramsay; Marc A Rodger; Marc Carrier; Vi Dao; Michael J Kovacs; Alejandro Lazo-Langner; Agnes Y Y Lee; Jerry Zhang; Philip S Wells
Development of a clinical prediction rule for risk stratification of recurrent venous thromboembolism in patients with cancer-associated venous thromboembolism.
Circulation 2012;126(4):448-54.
2012: Laura Hopkins; Vilma Luna; Marie Plante; Marc Carrier; Walter Gotlieb; Lisa Rambout
Surgical venous thromboprophylaxis: a cross-sectional survey of canadian gynaecologic oncologists.
Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstétrique et gynécologie du Canada : JOGC 2012;34(7):673-7.
2011: A Hamadah; Michael J Kovacs; Grégoire LE GAL; T Alwasaidi; Marc Carrier; Melissa A Forgie; C Gonsalves; D Scarvelis; Philip S Wells; Marc A Rodger
Baseline imaging after therapy for unprovoked venous thromboembolism: a randomized controlled comparison of baseline imaging for diagnosis of suspected recurrence.
Journal of thrombosis and haemostasis : JTH 2011;9(12):2406-10.
2011: Karim Abou-Nassar; Marc Carrier; Tim Ramsay; Marc A Rodger
The association between antiphospholipid antibodies and placenta mediated complications: a systematic review and meta-analysis.
Thrombosis research 2011;128(1):77-85.
2011: Marc Carrier; Marc Righini; Marc A Rodger; Philip S Wells; Grégoire LE GAL
Residual vein obstruction to predict the risk of recurrent venous thromboembolism in patients with deep vein thrombosis: a systematic review and meta-analysis.
Journal of thrombosis and haemostasis : JTH 2011;9(6):1119-25.
2011: Grégoire LE GAL; Marc Righini; Susan Solymoss; L Vickars; Philip S Wells; Richard H White; D A Anderson; M T Betancourt; Marc Carrier; I Chagnon; M Crowther; A Delluc; Susan R Kahn; Michael J Kovacs; Marc A Rodger
Residual vein obstruction as a predictor for recurrent thromboembolic events after a first unprovoked episode: data from the REVERSE cohort study.
Journal of thrombosis and haemostasis : JTH 2011;9(6):1126-32.
2011: Marc Carrier; Grégoire LE GAL; J Tay; C Wu; Agnes Y Y Lee
Rates of venous thromboembolism in multiple myeloma patients undergoing immunomodulatory therapy with thalidomide or lenalidomide: a systematic review and meta-analysis.
Journal of thrombosis and haemostasis : JTH 2011;9(4):653-63.
2010: Marc Carrier; Grégoire LE GAL; Hardy Tao; Philip S Wells; Kim Danovitch; Angele Mbanga-levac; Marc A Rodger
Should we screen patients with unprovoked venous thromboembolism for occult cancers? A pilot study.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2010;21(7):709-10.
2010: Marc A Rodger; Grégoire LE GAL; Marc Carrier; M T Betancourt; Susan R Kahn; Philip S Wells; D A Anderson; K Lacut; I Chagnon; Susan Solymoss; M Crowther; A Perrier; Richard H White; L Vickars; T Ramsay; Michael J Kovacs
Serum lipoprotein (a) levels in patients with first unprovoked venous thromboembolism is not associated with subsequent risk of recurrent VTE.
Thrombosis research 2010;126(3):222-6.
2010: Marc Carrier; Marc Righini; Philip S Wells; Arnaud Perrier; David R Anderson; Marc A Rodger; S Pleasance; Grégoire LE GAL
Subsegmental pulmonary embolism diagnosed by computed tomography: incidence and clinical implications. A systematic review and meta-analysis of the management outcome studies.
Journal of thrombosis and haemostasis : JTH 2010;8(8):1716-22.
2010: Marc A Rodger; Marc Carrier; E Gandara; Grégoire LE GAL
Unprovoked venous thromboembolism: Short term or indefinite anticoagulation? Balancing long-term risk and benefit.
Blood reviews 2010;24(4-5):171-8.
2010: Marc A Rodger; Marisol T Betancourt; Peter Clark; Pelle G Lindqvist; Donna Dizon-Townson; Joanne Said; Uri Seligsohn; Marc Carrier; Ophira Salomon; Ian A Greer
The association of factor V leiden and prothrombin gene mutation and placenta-mediated pregnancy complications: a systematic review and meta-analysis of prospective cohort studies.
PLoS medicine 2010;7(6):e1000292.
2010: Marc Carrier; Grégoire LE GAL; Philip S Wells; Marc A Rodger
Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism.
Annals of internal medicine 2010;152(9):578-89.
2010: A Y-H Shen; Grégoire LE GAL; C Dennie; Philip S Wells; Marc Carrier
Incidence and clinical outcomes of occult cancers detected by computed tomographic pulmonary angiography in patients with acute pulmonary embolism.
Journal of thrombosis and haemostasis : JTH 2010;8(5):1128-9.
2010: Grégoire LE GAL; Marc Carrier; S Tierney; H Majeed; Marc A Rodger; Philip S Wells
Prediction of the warfarin maintenance dose after completion of the 10 mg initiation nomogram: do we really need genotyping?
Journal of thrombosis and haemostasis : JTH 2010;8(1):90-4.
2009: Philip S Wells; Grégoire LE GAL; Sarah Tierney; Marc Carrier
Practical application of the 10-mg warfarin initiation nomogram.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2009;20(6):403-8.
2009: Marc Carrier; Grégoire LE GAL; R Cho; S Tierney; Marc A Rodger; Agnes Y Y Lee
Dose escalation of low molecular weight heparin to manage recurrent venous thromboembolic events despite systemic anticoagulation in cancer patients.
Journal of thrombosis and haemostasis : JTH 2009;7(5):760-5.
2009: Grégoire LE GAL; Michael J Kovacs; Marc Carrier; K Do; Susan R Kahn; Philip S Wells; D A Anderson; I Chagnon; Susan Solymoss; M Crowther; Marc Righini; A Perrier; Richard H White; L Vickars; Marc A Rodger
Validation of a diagnostic approach to exclude recurrent venous thromboembolism.
Journal of thrombosis and haemostasis : JTH 2009;7(5):752-9.
2009: Marc Carrier; Agnes Y Y Lee
Prophylactic and therapeutic anticoagulation for thrombosis: major issues in oncology.
Nature clinical practice. Oncology 2009;6(2):74-84.
2008: Marc Carrier; Grégoire LE GAL; Philip S Wells; Dean Fergusson; Tim Ramsay; Marc A Rodger
Systematic review: the Trousseau syndrome revisited: should we screen extensively for cancer in patients with venous thromboembolism?
Annals of internal medicine 2008;149(5):323-33.
2008: Marc Carrier; Agnes Y Y Lee; Shannon M Bates; David R Anderson; Philip S Wells
Accuracy and usefulness of a clinical prediction rule and D-dimer testing in excluding deep vein thrombosis in cancer patients.
Thrombosis research 2008;123(1):177-83.
2008: Marc Carrier; Philip S Wells
Should we regionalize the management of pulmonary embolism?
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 2008;178(1):58-60.
2007: Marc Carrier; Greg A Knoll; Michael J Kovacs; Jane C Moore; Dean Fergusson; Marc A Rodger
The prevalence of antibodies to the platelet factor 4 -heparin complex and association with access thrombosis in patients on chronic hemodialysis.
Thrombosis research 2007;120(2):215-20.
2006: Marc Carrier; Philip S Wells; Marc A Rodger
Excluding pulmonary embolism at the bedside with low pre-test probability and D-dimer: safety and clinical utility of 4 methods to assign pre-test probability.
Thrombosis research 2006;117(4):469-74.
2003: Marc A Rodger; Marc Carrier; Muriel Gervais; Gail Rock
Normal functional protein S activity does not exclude protein S deficiency.
Pathophysiology of haemostasis and thrombosis 2003;33(4):202-5.
2003: Marc A Rodger; Christine Gagné-Rodger; Heather E A Howley; Marc Carrier; Douglas Coyle; Philip S Wells
The outpatient treatment of deep vein thrombosis delivers cost savings to patients and their families, compared to inpatient therapy.
Thrombosis research 2003;112(1-2):13-8.
2002: Marc A Rodger; Marc Carrier; Erin Keely; Alan Karovitch; Carl Nimrod; Mark Walker; Philip S Wells
The management of thrombophilia during pregnancy: a Canadian survey.
Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstétrique et gynécologie du Canada : JOGC 2002;24(12):946-52.